The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dutoit, V.
Right arrow Articles by Valmori, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dutoit, V.
Right arrow Articles by Valmori, D.
The Journal of Immunology, 2003, 170: 5110-5117.
Copyright © 2003 by The American Association of Immunologists

Decreased Binding of Peptides-MHC Class I (pMHC) Multimeric Complexes to CD8 Affects Their Binding Avidity for the TCR But Does Not Significantly Impact on pMHC/TCR Dissociation Rate1

Valérie Dutoit2,*,{dagger}, Philippe Guillaume2,{ddagger}, Maha Ayyoub*,{dagger}, Charles S. Hesdorffer{dagger}, Immanuel F. Luescher{ddagger} and Danila Valmori3,*,{dagger}

* Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (Centre Hospitalier Universitaire Vaudois), Lausanne, Switzerland; {dagger} Ludwig Institute Clinical Trial Center, Division of Medical Oncology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032; and {ddagger} Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Lausanne, Switzerland

The CD8 coreceptor plays a crucial role in both T cell development in the thymus and in the activation of mature T cells in response to Ag-specific stimulation. In this study we used soluble peptides-MHC class I (pMHC) multimeric complexes bearing mutations in the CD8 binding site that impair their binding to the MHC, together with altered peptide ligands, to assess the impact of CD8 on pMHC binding to the TCR. Our data support a model in which CD8 promotes the binding of TCR to pMHC. However, once the pMHC/TCR complex is formed, the TCR dominates the pMHC/TCR dissociation rates. As a consequence of these molecular interactions, under physiologic conditions CD8 plays a key role in complex formation, resulting in the enhancement of CD8 T cell functions whose specificity, however, is determined by the TCR.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. S. Chervin, J. D. Stone, P. D. Holler, A. Bai, J. Chen, H. N. Eisen, and D. M. Kranz
The Impact of TCR-Binding Properties and Antigen Presentation Format on T Cell Responsiveness
J. Immunol., July 15, 2009; 183(2): 1166 - 1178.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Wooldridge, H. A. van den Berg, M. Glick, E. Gostick, B. Laugel, S. L. Hutchinson, A. Milicic, J. M. Brenchley, D. C. Douek, D. A. Price, et al.
Interaction between the CD8 Coreceptor and Major Histocompatibility Complex Class I Stabilizes T Cell Receptor-Antigen Complexes at the Cell Surface
J. Biol. Chem., July 29, 2005; 280(30): 27491 - 27501.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. O. Holman, E. R. Walsh, and S. C. Jameson
Characterizing the Impact of CD8 Antibodies on Class I MHC Multimer Binding
J. Immunol., April 1, 2005; 174(7): 3986 - 3991.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Mayr, D. Bund, M. Schlee, A. Moosmann, D. M. Kofler, M. Hallek, and C.-M. Wendtner
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes
Blood, February 15, 2005; 105(4): 1566 - 1573.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. M.-L. Choi, J.-L. Chen, L. Wooldridge, M. Salio, A. Lissina, N. Lissin, I. F. Hermans, J. D. Silk, F. Mirza, M. J. Palmowski, et al.
High Avidity Antigen-Specific CTL Identified by CD8-Independent Tetramer Staining
J. Immunol., November 15, 2003; 171(10): 5116 - 5123.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.